Company or institution

Lantern Pharma Inc.

Save Like

31 applicationsfiled 2007 to 2026

Allowance rate

75%

level with the USPTO range 51% to 90%

Rejections before allowance

1.3

−0.3 vs the USPTO

Months to first action

27.0 mo

+8.4 vs the USPTO

Needed an RCE

31%

+4 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations22 apps

A61P Therapeutic activity of compounds4 apps

C07C 2 apps

G16B Bioinformatics1 apps

G16C 1 apps

C12Q Measuring or testing processes involving enzymes or nucleic acids1 apps

Art units

OPAP6 apps

16545 apps

16213 apps

16292 apps

16252 apps

16992 apps

Examiners met

The examiners seen most, and how it went with each

Docket Central6 apps

n/a

Andrew D Kosar6 apps

100%

Amy C Bonaparte2 apps

100%

Noble E Jarrell2 apps

n/a

James D Anderson1 apps

100%

Steven C Pohnert1 apps

n/a

Yan Xiao1 apps

100%

Jerica Katlynn Wilson1 apps

n/a

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Lantern Pharma Inc.18 apps

67%

BioNumerik Pharmaceuticals, Inc.8 apps

88%

GREENBERG TRAURIG LLP (GT)4 apps

50%

Greenberg Traurig (WPB)1 apps

n/a

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19569622	LYOPHILIZED HYDROXYUREAMETHYL ACYLFULVEN	2026-03-17	Pending	0	0	n/a
19546266	TREATING LIVER CANCERS WITH HYDROXYUREAMETHYL ACYLFULVENE	2026-02-20	Pending	0	0	n/a
19405201	TREATING CANCERS WITH COMBINATIONS OF ANTI-CD20 ANTIBODY AND ACYLFULVENES	2025-12-01	Pending	0	0	n/a
15689646	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15978445	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15265428	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15167789	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15841761	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15821574	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15771218	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 31 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in